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Background: A higher prevalence of chronic atrophic gastritis (CAG) occurs in younger adults in Asia. We used
Stomach Age to examine the different mechanisms of CAG between younger adults and elderly individuals, and
established a simple model of cancer risk that can be applied to CAG surveillance.
Methods: Stomach Age was determined by FISH examination of telomere length in stomach biopsies. Δψm was
also determined by flow cytometry. Sixty volunteers were used to confirm the linear relationship between telomere
length and age while 120 subjects were used to build a mathematical model by a multivariate analysis. Overall, 146
subjects were used to evaluate the validity of the model, and 1,007 subjects were used to evaluate the relationship
between prognosis and Δage (calculated from the mathematical model). ROC curves were used to evaluate the
relationship between prognosis and Δage and to determine the cut-off point for Δage.
Results: We established that a tight linear relationship between the telomere length and the age. The telomere
length was obvious different between patients with and without CAG even in the same age. Δψm decreased in
individuals whose Stomach Age was greater than real age, especially in younger adults. A mathematical model of
Stomach Age (real age + Δage) was successfully constructed which was easy to apply in clinical work. A higher
Δage was correlated with a worse outcome. The criterion of Δage >3.11 should be considered as the cut-off to
select the subgroup of patients who require endoscopic surveillance.
Conclusion: Variation in Stomach Age between individuals of the same biological age was confirmed. Attention
should be paid to those with a greater Stomach Age, especially in younger adults. The Δage in the Simple Model
can be used as a criterion to select CAG patients for gastric cancer surveillance.
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Chronic atrophic gastritis (CAG) was listed as precancer-
ous condition for gastric cancer by the WHO in 1978. It
has been observed that a moderately increased risk of gas-
tric cancer with the presence of CAG after 10 years of
follow-up [1]. Because CAG tends to be lifelong, and* Correspondence: jingyuanfang2007@126.com
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reproduction in any medium, provided the orspontaneous healing is rare [2], it is no doubt that younger
adults with CAG would have a higher risk of gastric can-
cer due to the long duration of disease.
Some experts believe that the pathological degen-
erative changes of CAG may be a semi-physiological
phenomenon especially in the elderly population [3].
However, a high prevalence among younger adults is
found in some high-risk regions for gastric cancer in
Asia [4]. Our research seeks to investigate the differ-
ent underlying causes of CAG between different age
groups.
Telomere erosion can be regarded as a biological
clock [5]. As telomeres shorten with age in humans and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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shortened telomeres, it has been proposed that telomere
length is an important parameter in aging. Telomere
length reduction has been confirmed in diseases such
as hypertension [6], diabetes and coronary heart disease
[7,8], and it has been also confirmed in cells of the human
thyroid and parathyroid [9], as well as liver, kidney and
skin [10]. However, whether this is also the case with
CAG or in the stomach aging process remains unclear.
To address these questions, the quantification of telo-
mere length is essential. Recent studies have described a
method of fluorescence in situ hybridization (FISH) that
is faster and more reliable than comparable techniques
[11-14], which can also be applied to paraffin-embedded
tissue samples [15]. Using FISH, we were able to meas-
ure the telomere length of chromosomes in stomach
cells from biopsy samples obtained by endoscopy.
In this study, we define a new term of “Stomach Age”,
which can be used to evaluate the aging of the stomach
and is based on the telomere length of stomach cells. We
attempted to use this concept to explain the phenomenon
of CAG in younger adults and to establish a simple math-
ematical model to calculate Stomach Age, which can be
applied clinically for prognostication.
Methods
Study subjects and archived tissue samples to establish
the Stomach Age model
Tissue samples were obtained from the pathology archives
of the GI Division at Shanghai Jiao-Tong University
School of Medicine, Renji Hospital and eight other med-
ical centers (Military General Hospital of Beijing PLA,
First Affiliated Hospital of Nanchang University, First
Affiliated Hospital of Nanjing Medical University, First
Affiliated Hospital of Anhui University, First Affiliated
Hospital of Soo-Chow University, Qilu Hospital of
Shandong University, Second Military Medical University,
Changhai Hospital and Changzheng Hospital). Formalin-
fixed paraffin-embedded blocks were retrieved from 246
subjects (60 healthy volunteers and 186 out-patients at
gastrointestinal clinical departments) who underwent en-
doscopy. At least two biopsies were taken from the an-
trum and corpus on both the greater curvature and the
lesser curvature of the stomach, and then routinely em-
bedded in paraffin blocks, sectioned and stained. Tissue
sections (3–4 μm) from each sample were used for the
histopathological examination and FISH. Another two bi-
opsies taken from the antrum were preserved in liquid ni-
trogen and kept at −80°C for flow cytometry.
Study population to evaluate the predictive ability of the
Stomach Age model
Relevant information from 1,200 patients at the Shanghai
Jiao-Tong University School of Medicine, Renji Hospitalwas analyzed. At the baseline timepoint, all participants
underwent endoscopic examination with biopsies, which
were repeated at least once at subsequent visits during the
follow-up period. The relevant information regarding the
histological results and the answers to the questionnaire,
described below, were recorded and compared between
age groups.
Questionnaire
We interviewed all participants using a standard self-
administered questionnaire to assess baseline character-
istics. The mean time for completing the questionnaire
was approximately 15–20 minutes. The questionnaire
included the following: 1) demographic factors; 2) any
family history of medical conditions, including cancer; 3)
a detailed medication history; 4) sleeping habits and
quality, and job pressures; 5) the number of cigarettes
smoked per day and the duration of smoking; 6) the fre-
quency and amount of water, milk, beverages, wine and
hard liquor taken; 7) tea and coffee drinking habits; 8)
the consumption of rice, meat, fish, vegetables, fruits,
pickled vegetables or salted fermented products, and dehy-
drated foods; and 9) favorite flavors, cooking methods, and
intake of night snacks.
Histopathological diagnosis and Helicobacter pylori
infection assessment
Each stained slide was examined independently by two
experienced pathologists who were unaware of the indi-
vidual’s clinical details using the updated Sydney classifi-
cation [16]. When there were disagreements, the biopsies
were re-examined until agreement was reached. Two
histopathological entities were defined: chronic non-
atrophic gastritis (CNAG) and CAG. CNAG was de-
fined as any grade of inflammation with no atrophy in
both the corpus and the antrum. CAG was defined as at-
rophy or/and intestinal metaplasia (IM) in either the
corpus or the antrum. The histological features of the bi-
opsies were recorded as slight, moderate, or severe ac-
cording to the Sydney scoring system. Patients with no or
inadequate biopsies were excluded from the study. Helico-
bacter pylori infection was detected by either rapid urease
testing of biopsy samples or [13] 13-C urease breath test.
FISH
Hybridization was performed according to the manufac-
turer’s instructions. Briefly, slides were deparaffinized
and rehydrated through a series of ethanol gradients,
treated with 0.1% Tween 20 detergent in de-ionized
water, incubated in citrate buffer (Target Unmasking So-
lution; Vector Laboratories, Burlingame, USA) in steam,
immersed in de-ionized water and fixed in ethanol gradi-
ents, and air-dried. Approximately 10 μl of PNA probe
was added to each slide. The PNA probe for telomeric
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Telomere PNA Fish Kit/FITC (K5327; DakoCytomation
A/S, Glostrup. Denmark). The slides were then cover-
slipped, incubated at 84°C for 5 min, and hybridized for
2 h at room temperature in the dark. After extensive
washing, first at 65°C and then at room temperature
with PBST. The nuclei were then stained with DAPI
(1 μg/ml, Molecular Probes, Eugene, OR), after washed in
stilled water, the slides were mounted with antifade
mounting media (Prolong™ Anti-fade Mounting Media;
Molecular Probes, Eugene, OR, USA).
Microscopy and data analysis
Slides were imaged using an epifluorescence microscope
(Nikon Eclipse 80i). The fluorescence excitation/emis-
sion filters used were FITC 490 nm BP excitation via a
XF38 filter set. Fluorescence images were captured with
a cooled charge-coupled device camera (Nikon DSRil).
For the tissue section, the calculated areas were identi-
fied according to the H&E-stained slides before the
fluorescence microscopy which contained the epithelial
cells and the glands (pyloric glands in antrum and fundic
glands in corpus). After that the calculated areas were
divided into five regions automatically by the profes-
sional software (Image-Pro Plus 6.0). At least 1000 nu-
clei were calculated in each region. Five regions of each
tissue section were examined for telomere labeling; the
intensity of the fluorescence was utilized to reflect this.
Telomere signals were quantitated by a method validated
recently in which the sum of pixel intensities in the
FITC channel for a given cell nucleus is normalized to
the DAPI signal. DAPI staining provides a robust meas-
ure of DNA content, being largely insensitive to cell
type, proliferation status, and degree of chromatin con-
densation [17-19]. Each region of the tissue section was
examined for telomere labeling independently by two ex-
perienced technicians at different time. The correlation
coefficients were estimated.
Flow cytometry and measurement of Δψm
Δψm, the voltage across the inner mitochondrial mem-
brane, can be altered by oxidative damage, such as that
which occurs during the aging process. Studies showed
that Δψm decreased gradually with age [20,21]. So we
believed that Δψm can be used to evaluate the aging of
the stomach and as a measurement to validate the term
of “Stomach Age”. To support our study, we determined
the value of Δψm of those patients. Antrum biopsy sam-
ples were first prepared as single cell suspensions using
a tissue dissociation kit according to the manufacturer’s
protocol (KGA829, KeyGEN Biology Co., Ltd, Nanjing,
China). For staining, the cells were incubated with JC-1
(Molecular Probes, Invitrogen, Germany) for 30 min at
37°C in the dark. The cells were then washed in PBS andanalyzed immediately by flow cytometry (FACScan; BD
Biosciences, Franklin Lakes, NJ, USA). A total of 10,000
cells were examined for green fluorescence using a
529 nm filter and for orange fluorescence using a 590 nm
filter. All data were analyzed using BD Cell Quest Pro
Software (BD Biosciences).
Statistical analysis
Statistical analysis was performed using SPSS 17.0 statis-
tical software. The paired t-test, Chi-square test and ana-
lysis of variance were used. All data were presented as
the mean ± SE. Differences were considered to be statis-
tically significant at P < 0.05. Multivariate analysis was
performed by logistic regression using a backward elim-
ination procedure for variables not significantly associ-
ated with the Δage (Stomach Age-real age; P = 0.05) [22].
The sensitivity and specificity of the models were calcu-
lated. The performance of the predictive model was
assessed by the area under the receiver operating charac-
teristic curve (AUROC). We chose the highest Youden’s
index as the optimal cut-off point [23].
Ethics
The study protocol was accepted by the Renji Hospital
Ethics Committee (Shanghai, China). Each participant
was required to sign an informed consent form.
Results
Linear relationship between telomere length and age in
stomach cells
In order to evaluate the Stomach Age, we aimed to es-
tablish the standard criteria of Stomach Age in healthy
people. Sixty antrum biopsies from healthy volunteers
were used to establish the standard criteria. These in-
cluded 30 males and 30 females aged 23–76 years, in
whom endoscopy showed a generally normal gastric lin-
ing and in whom the Stomach Age was considered to be
the same as their real age. Five regions of each tissue
section were examined for the intensity of telomere la-
beling; the average intensity was used for the regression
equation. The mean coefficient of variation was 0.097
which we consider satisfactory. The volunteers’ charac-
teristics and fluorescence intensity are listed in Table 1.
As demonstrated in Figure 1, a tight linear relationship
(goodness of fit: r2 = 0.8263) existed between the inten-
sity of telomere labeling and the age. The equation of
the computed regression line is x (years) = (17.719–y)/
0.174. In this equation, y was the value of fluorescence
intensity on FISH and x was the age. The correlation
coefficient between FISH data and age is r = √0.8263 =
0.91. Thus, we clearly demonstrated a linear decline in
telomere length with age increasing. By using the equa-
tion above the biological aging level of stomach (Stom-
ach Age) of every one could be expressed precisely in
Table 1 The characteristics and fluorescence intensity of volunteers
Age range (years) 21-30 31-40 41-50 51-60 61-70 71-80
Total number 6 12 9 15 12 6
Number of male 3 9 6 9 6 3
Fluorescence intensity (mean ± SD) 14.8 ± 0.69 11.8 ± 0.92 9 ± 1.07 7.87 ± 1.64 6.18 ± 0.76 6.15 ± 0.04
Occupation
Student 3 0 0 0 0 0
Professional 0 4 4 2 1 0
Administrative 0 2 1 3 1 0
Sales 1 3 1 0 0 0
Blue-collar 1 2 1 0 0 0
Freelance 1 1 2 0 0 0
Retired 0 0 0 10 10 6
Family history
Stomach cancer 0 0 0 0 0 0
Other cancer 0 0 1 0 0 0
History of peptic ulcer 0 0 0 0 0 0
Smoking status & history 0 2 2 1 1 0
Seldom 0 1 0 0 1 0
<10 cigarettes per day 0 1 2 1 0 0
10-20 cigarettes per day 0 0 0 0 0 0
>20 cigarettes per day 0 0 0 0 0 0
Less than 5 years 0 1 0 0 0 0
5-10 years 0 1 1 0 0 0
More than 10 years 0 0 1 1 1 0
Alcohol drinking habits 0 2 1 2 1 0
<250 ml per day 0 2 1 2 0 0
>250 ml per day 0 0 0 0 0 0
Less than 5 years 0 1 0 0 0 0
More than 5 years 0 1 1 2 1 0
Coffee habits 2 1 0 0 0 0
Tea drinking habits 1 2 2 1 0 1
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pared individually.
Different telomere lengths between CAG and CNAG
patients
Secondly, we found that telomere length was obvious
different between patients with and without CAG. At
the same age, the intensity of the fluorescence of was
lower in CAG patients than CNAG patients (Figure 2),
which suggests that CAG may accelerate stomach aging.
This change can make the degree of stomach aging in
young patients with CAG equivalent to that of elderly
individuals. Therefore, we postulated that people of the
same biological age may have a different Stomach Age,
which could be influenced by risk factors such as gastric
atrophy and IM.Flow cytometry and measurement of Δψm
To obtain further evidence to support our hypothesis,
we determined the value of Δψm. If CAG do accelerate
stomach aging, the Δψm of those patients should de-
crease simultaneously.
JC-1(5′,6,6’-tetrachloro-1,1′3,3’-tetraethylbenzimidazo-
lylcarbocyanine iodide) can be used as an indicator of
mitochondrial potential, which, when damaged, plays a
central role in the aging process [24]. In cells that have
mitochondria with a high Δψm, JC-1 forms orange fluor-
escent J-aggregates (Q2 region), whereas in cells with
depolarized or damaged mitochondria, the sensor dye is
present as green fluorescent monomers (Q4 region). We
calculated the telomere length of enrolled subjects (146
subjects), and then obtained the Stomach Age of those
subjects by using the Stomach Age equation (obtained
Figure 1 Stomach Age of volunteers. The volunteers’ age and the intensity of fluorescence on fluorescence in situ hybridization are closely
correlated in a linear manner (r2 = 0.8263) when a simple regression analysis is applied (y = −0.174x + 17.719, where y is fluorescence intensity and
x is Stomach Age). Rearranging this equation, the Stomach Age model is x (years) = (17.719 –y)/0.174.
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their Δψm values.
We defined individuals below 50 years of age as the
younger adult group, and individuals aged ≥50 years
were the older adult group (Figure 3). In CNAG patients
of younger adults, the Stomach Ages were younger than
or equal to their real age, most of the sample cells were
localized in the Q2 region (high Δψm). However, in
CAG patients of younger adults, the Stomach Ages were
greater than their real age, most cellular dots shifted
from Q2 to the Q4 region, indicating a loss of Δψm, and
the relative ratio of cellular dots in the Q2 regions de-
creased significantly (P < 0.05). The same trend occurred
in the older adults, but the shift in ratio was not as great
as in the younger group. These results indicate that
CAG could accelerate stomach aging accompany withFigure 2 Fluorescence in situ hybridization (FISH) of stomach biopsies. F
endoscopy. Telomeres are stained with a FITC-labeled antitelomeric probe and
demonstrates strong telomeric signals in normal stomach. Picture B (male, 40 y
demonstrates weak telomeric signals in atrophic tissue, indicating that CAG mathe decreasing of Δψm. The Δψm was decreased in indi-
viduals whose Stomach Age was greater than their real
age, especially in younger adults (P < 0.05). Stomach Age
can represent the biological age of the stomach more
precisely than the true biological age.
Evaluation and establishment of the Simple Model in a
multicenter study
For use in clinical practice, we tried to modify the equa-
tion of the Stomach Age to obtain a Simple Model. 120
samples including 60 volunteers were used (The detailed
characteristics are listed in Table 2). Firstly, we measured
the samples’ intensity on FISH, and then calculated each
individual’s Stomach Age using the equation.
We also collected their baseline variables from a ques-
tionnaire and the histological information, and several riskISH was performed on biopsy samples obtained from patients by
are colored green. Picture A (male, 40 years old, endoscopy result: CNAG)
ears old, endoscopy result: CAG with moderate intestinal metaplasia)
y accelerate aging of the stomach. Original magnification: ×40 (A, B).
Figure 3 Measurement of mitochondrial membrane potential (Δψm). A) Overall, 90.82% of cells in the Q2 region and only 2.03% in Q4 (male,
32 years old, Stomach Age 31 years, endoscopy result: CNAG); B) 83.91% of cells in Q2 and 13.49% in Q4 (female, 77 years old, Stomach Age 76 years,
endoscopy result: CNAG); C) 69.06% of cells in Q2 and 25.92% in Q4 (female, 30 years old, Stomach Age 52 years, endoscopy result: CAG with slight
atrophy and intestinal metaplasia); D) 65.29% of cells in Q2 and 31.37% in Q4 (female, 65 years old, Stomach Age 74 years, endoscopy result: CAG
with slight atrophy and moderate intestinal metaplasia). The difference is significant within each group and between the two groups (P < 0.05).
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age) were analyzed by multivariate regression analysis
using SPSS 17.0. After backward selection, several factors
remained in the final model, as shown in Table 3, the Sim-
ple Model was found to be:
Δage ¼ 1:87–0:45  X1–3:39  X2 þ 1:72  X3
þ 3:15  X4 þ 13:99  X5 þ 18:62
 X6–16:96  X7 þ 18:16  X8;
andStomach Age yearsð Þ ¼ real age þ Δage:
The Hosmer–Lemeshow goodness-of-fit test suggested
that the model was well calibrated (P > 0.05).
One-hundred and forty-six subjects from multiple
centers were used to evaluate the accuracy of the Simple
Model. For each subject, Stomach Age was determined
using both the samples’ intensity on FISH and the Simple
Models. The paired t-test was used to compare the two
results, and no significant difference was found (P > 0.05,
detailed materials were shown in Figure 4), which indicates
Table 2 The baseline variables and histological evaluation of 120 subjects for the establish model
Number of male Number of female
(30 out-patients/30 healthy volunteers) (30 out-patients/30 healthy volunteers)
Age range <30 30-39 40-49 50-59 60-69 >69 <30 30-39 40-49 50-59 60-69 >69
Number 5 12 14 10 14 5 5 11 17 11 12 4
H.pylori infection positive 1 2 1 2 0 0 1 2 3 2 1 0
Histopathologic results
Atrophy 2 3 8 1 8 2 2 8 14 5 6 1
Intestinal metaplasia 0 1 4 1 6 1 1 4 10 3 4 1
Mild Dysplasia 0 0 0 1 1 1 0 0 1 0 0 0
Occupation
Students 2 0 0 0 0 0 3 0 0 0 0 0
Professional 0 2 2 1 1 0 0 5 4 1 0 0
Administrative 0 1 1 2 1 0 0 1 5 1 0 0
Sales 1 2 1 1 3 0 1 1 2 0 0 0
Blue-collar 1 3 5 1 0 0 0 1 1 0 0 0
Freelance 1 4 5 0 2 0 1 3 5 2 7 0
Retired 0 0 0 5 7 5 0 0 0 7 5 4
High job pressure 3 3 4 3 3 0 1 5 8 1 2 0
Sleeping time
>8 h 1 5 4 2 3 0 1 4 3 5 1 0
6-8 h 3 2 5 2 3 5 3 2 7 5 5 2
<6 h 1 5 5 6 8 0 1 5 7 1 6 2
Poor quality of sleeping 1 4 1 1 2 1 1 2 0 2 1 1
Family history
Stomach cancer 1 0 0 1 0 0 1 0 0 0 0 1
Other cancer 1 0 1 0 0 0 0 0 0 1 0 0
History of peptic ulcer 1 0 1 0 0 0 1 0 2 1 0 0
Smoking status & history
Seldom 0 1 0 1 1 0 0 1 0 0 0 0
<10 cigarettes per day 0 2 2 1 2 1 0 0 0 0 0 0
10-20 cigarettes per day 0 0 0 0 0 0 0 0 0 0 0 0
>20 cigarettes per day 0 0 0 0 0 0 0 0 1 0 0 0
Less than 5 years 0 2 0 0 0 0 0 1 0 0 0 0
5-10 years 0 1 1 1 0 0 0 0 0 0 0 0
More than 10 years 0 0 1 1 3 1 0 0 1 0 0 0
Coffee habits 0 1 1 0 0 0 2 2 1 2 1 0
Less than 5 years 0 1 1 0 0 0 2 1 0 1 1 0
More than 5 years 0 0 0 0 0 0 0 1 1 1 0 0
Tea drinking habits
Green tea 2 4 3 4 2 2 0 3 0 1 0 0
Black tea 0 1 1 0 0 0 0 0 1 2 0 0
Others 0 0 0 2 0 0 0 0 1 0 0 0
Less than 5 years 1 4 0 3 0 0 0 1 0 0 0 0
More than 5 years 1 1 4 3 2 2 0 2 2 3 0 0
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Table 2 The baseline variables and histological evaluation of 120 subjects for the establish model (Continued)
Alcohol drinking habits 0 4 3 2 1 0 0 0 0 0 0 0
<250 ml per day 0 2 3 2 0 0 0 0 0 0 0 0
>250 ml per day 0 2 0 0 0 0 0 0 0 0 0 0
Less than 5 years 0 3 0 0 0 0 0 0 0 0 0 0
More than 5 years 0 1 3 2 1 0 0 0 0 0 0 0
Spicy flavors 1 2 2 1 0 0 1 3 3 2 1 1
Regular meals 5 5 9 6 8 4 1 5 7 6 10 4
Lengths of meals
<10 minutes 4 4 5 2 1 0 3 2 5 4 3 0
10-30 minutes 0 8 8 3 10 2 2 3 10 5 8 1
>30 minutes 1 0 1 5 3 3 0 6 2 2 1 3
Drinking liquid at eating time 2 5 8 6 5 2 5 3 10 2 3 2
Consumption of milk 2 7 7 5 4 2 3 9 8 5 6 2
Consumption >2 per week
Salted fermented products 0 5 3 4 7 2 1 5 5 6 4 1
Desserts 2 2 3 0 3 0 4 2 4 3 1 0
Dehydrated foods 2 3 3 0 1 0 2 4 2 1 0 0
Fried foods 1 6 2 2 1 0 3 4 8 4 4 0
Leftovers 2 6 6 3 10 5 0 4 11 9 5 1
Seafood 1 7 7 1 2 0 3 5 3 2 3 1
Pickled vegetables 0 1 0 2 3 2 0 2 4 6 2 2
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instead of the FISH.
The relationship between Δage and prognosis in a large
sample study
Overall, 1,200 patients were recruited in the study, sub-
jects were asked to reply to the standard questionnaire,
which encompassed the eight factors in the Simple
Model of Stomach Age, by telephone or letter. A total of
1,007 subjects, 457 male and 560 female, returned com-
pleted questionnaires. The average duration of follow-up
was 5.4 years (range, 12 months to 190 months).Table 3 Multivariate logistic regression model for simple Stom
Variable Pa
Intercept 1.8




X4 intestinal metaplasia (none 0, mild 1, moderate 2, severe 3) 3.1
X5 family history of gastric cancer (yes 1, no 0) 13
X6 accompany with cardiovascular disease (yes 1, no 0) 18
X7 accompany with Gastro-esophageal reflux disease (yes 1, no 0) −1
X8 times of fast and junk food per week 18We calculated the Stomach Age of each subject by the
Simple Model, and the Δage were recorded. The histo-
logical results at the beginning and the end of the
follow-up period were compared individually. On the
basis of the comparison of histological results, 1,007
subjects were divided into three groups: Group A (329
subjects), whose histological results had improved after
follow-up as the degree of inflammation or/and atrophy
or/and IM was reduced after; Group B (320 subjects), in
whom there was no change after follow-up; and Group
C (358 subjects), whose biopsy results worsened, mean-
ing the degree of inflammation or/and atrophy or/andach Age
rameter estimate Standard error F value Pr > F
704 0.4832 16.68 <.0001
.44783 0.25975 11.27 0.0010
.39746 1.84974 6.19 0.0139
1968 0.76847 8.81 0.0035
5415 1.59460 15.99 0.0001
.99844 5.82543 5.77 0.0202
.62093 5.95565 9.78 0.0030
6.95696 4.90988 13.09 0.0004
.16387 3.57430 10.55 0.0014
Figure 4 No significant difference was found between the Simple Model and the FISH data (n = 146). For each subject, Stomach Age was
determined using both the samples’ intensity on FISH and the Simple Models. Each dot represents a subject. The error bars represent the
difference between the biological age which calculated from the samples’ intensity on FISH and the Simple Models of Stomach Age. Almost all
of the subjects showed a short error bars which indicates that the Simple Model can be used in clinical practice instead of the FISH. The paired
t-test was used to compare the two results, and no significant difference was found (P > 0.05).
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IM was present.
We found that in Group A, the majority of subjects
(75.99%) were Δage ≤ 0 (Stomach Age was younger than
or equal to their real age), and on the contrary, the ma-
jority of subjects in Group C (88.82%) were Δage > 0
(Stomach Age was greater than their real age). In mul-
tiple comparisons, there was a significant difference be-
tween these three groups (P < 0.01; Figure 5).
After this, we divided the 1,007 subjects into sub-
groups according to their real age in order to observe
whether there was a significant impact on prognosis ac-
cording to Stomach Age. The results showed that Stom-
ach Age could influence the prognosis of disease at all
biological ages analyzed (Table 4).Figure 5 The comparison of Δage in groups with a different
disease prognosis. In Group A (CAG improved), the majority of
subjects were Δage ≤0 (Stomach Age of these patients will be
younger than their real age) on the contrary, the majority of subjects
in Group C (worsened CAG) were Δage >0 (Stomach Age greater
than their real age). And no significant difference in the subjects
composition of Stomach Age in Group B (no change). In multiple
comparisons, there was a significant difference between the three
groups (P < 0.01), and the significant difference also existed between
each group (P < 0.01).Evaluate the predictive ability of the Simple Model of
Stomach Age
Using the Simple Model of Stomach Age, we obtained a
new variable (Δage) for all participants. We used the
pathological diagnosis as the gold standard, and divided
the 1,007 subjects into two groups: the poor prognosis
group (Group C) or better prognosis group (Groups A
and B on histology). Then, we analyzed the model by the
ROC curve and calculated the AUROC. The model
showed relatively good discrimination, with an AUROC
of 0.852 (95% CI, 0.829–0.876; Figure 6).
The sensitivity and specificity were calculated using
various cut-off points ranging from 0.0 to 1.0. We chose
the Youden’s index cut-off point that corresponded to
the maximal value as the new standard. A final probabil-
ity cut-off score of 3.11 was used to predict those at a
high risk of a poor prognosis (>3.11) or a low risk of a
poor prognosis (≤3.11). The sensitivity and specificity
were 82.7% and 71.8%, respectively.
Finally, we analyzed the effects of Δage on prognosis
using the Kaplan-Meier Survival Model (Figure 6). The
comparisons revealed that higher Δage (>3.11) was asso-
ciated with poor prognosis (P <0.01). This results indi-
cated that attention should be paid to those patients
whose Δage > 3.11, due to the potential poor prognosis.
Discussion
Aging is the progressive loss of metabolic and physio-
logical functions, but its trajectory is not uniform, which
suggests considerable variation exists in its biology [25].
This theory provides the basis of the concept of Stomach
Age. People of the same biological age may have different
Stomach Ages, and this variation may arise from a host of
genetic and environmental factors. With the use of Stom-
ach Age, we can differentiate between normal and abnor-
mal stomach aging (the CAG in younger adults).
Table 4 The comparasions between groups of different age
Age 20-39 40-49 50-59 60-69 70-79 ≥80
N* P# N P N P N P N P N P
GroupA Δage ≤ 0 8 25 75 79 53 12
Δage > 0 2 6 27 29 7 6
GroupB Δage ≤ 0 4 0.046 24 0.000 64 0.000 54 0.000 18 0.000 6 0.000
Δage > 0 8 16 50 52 17 7
GroupC Δage ≤ 0 2 7 7 11 8 1
Δage > 0 4 24 67 126 68 33
*N = number of patients.
#P = P value.
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correlated with age [26], and therefore the variation in
Stomach Age recorded by FISH analysis of stomach biopsy
samples could be an accurate means of describing the age
of the stomach. According to our study, CAG patients have
relatively shorter telomeres than normal and the Stomach
Age of these patients is greater than their real age,
which indicates that CAG could be regarded as a form
of stomach aging. Thus, CAG in younger adults could
be considered as premature aging of the stomach, which
is a pathological process, and the mechanism of CAG in
younger adults is quite different from that in more eld-
erly people.Figure 6 ROC curve and Kaplan-Meier survival curve of the accuracy
(95% CI 0.829–0.876), which indicates relatively good discrimination. It is an
Δage ≤3.11, and 358 cases with Δage > 3.11. The result revealed that highe
indicated that there was significant difference between the two groups (PFurther evidence to support this view is that the Δψm
in CAG patients was significantly decreased, especially
in younger adults. After exposure to the oxidative dam-
age that is thought to contribute to aging, mitochondria
are disproportionately damaged or destroyed and can-
not maintain their Δψm [27]. This phenomena exists
not only in many degenerative diseases (e.g., Parkinson’s
disease) [28], but also in aging cells [29]. Our finding
that the presence of CAG increased the decline of Δψm,
especially in younger adults (P < 0.05); this indicates that
CAG may accelerate aging in the stomach, leading to a
greater Stomach Age. From these results, we hypothesize
that Δage (Stomach Age - real age) could predict theof Δage for prognostication (n = 1007). The AUROC was 0.852
alyzed using Kaplan-Meier survival model, including 649 cases with
r Δage (>3.11) was associated with poor prognosis. The Chi-square test
< 0.01).
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aging of the stomach.
Moreover, age has been established as an independent
risk factor for the development of gastric cancer in CAG
patients, and a recent large cohort study showed that
the age at the initial diagnosis was associated with the
progression to more advanced lesions and to gastric
cancer [30]. We hypothesize that those with abnormal
biological stomach aging would have an increased risk of
gastric cancer than those with a normal Stomach Age.
Although Stomach Age can be determined by FISH,
the use of this method in large populations is unrealistic
due to its high cost. For this reason, we modified the
equation by logistic regression to obtain a simple form
for clinical use. The questionnaire we used included nu-
merous factors related to gastritis, which has been vali-
dated in previous studies [31-34]. To summary, firstly,we
focused on eight factors that affect Stomach Age by
using logistic regression (Table 3). There was no doubt
that the endoscopy results influenced the model. Atro-
phy and IM can increase Stomach Age, whereas inflam-
mation and its activity had no effect. Studies have shown
that CAG is likely to advance gradually with increasing
age, even in asymptomatic subjects [35] and there was
an upward age-related trend of the prevalence of IM
with increasing age [36], which is consistent with our re-
sults. Secondly, a family history of gastric cancer may
also increase Stomach Age. The relationship between
the family history of gastric cancer and the risk of CAG
is controversial [37,38]. Our results support the idea that
a family history of gastric cancer can accelerate aging of
the stomach, which may lead to increased CAG. Thirdly,
it is interesting that, in people with cardiovascular dis-
ease, aging of the stomach is accelerated, whereas the
presence of gastroesophageal reflux disease (GERD)
seems to have the reverse effect. This might be the result
of hyperhomocysteinemia [39]. In addition, certain med-
ications for the treatment of cardiovascular disease, such
as aspirin, can cause gastric damage both through topical
irritant effects on the epithelium and by systemic effects
related to the suppression of mucosal prostaglandin syn-
thesis [40], and thus may also lead to aging of the stom-
ach. Aging is reported to be correlated with esophageal
motor abnormalities such as GERD [41], but our findings
are not the same. We hypothesize that our model for the
determination of Stomach Age is more focused on secre-
tion than on motor ability, as it is based on FISH measure-
ments of telomere lengths, which are greater in normal
epithelial cells than atrophic tissues. The mucosa and
secretory glands are relatively complete in GERD; whether
this has any effect on the measured Stomach Age should
be investigated in future studies. Finally, junk food may
also play an important role in Stomach Age. A recent
study reported that trans fats, which are common in fastfood, can accelerate brain aging [42]. We hypothesize that
foods containing synthetic additives, such as preservatives,
or those with a high fat content could also increase the
Stomach Age.
Our study did not find any significant relationship
between H. pylori infection and aging, which differs
from the results of other studies [43,44]. There are at
least two possible reasons. Firstly, because most of
our patient information came from a cross-sectional study,
H. pylori infection could have been present once but have
been eliminated at the time of the biopsies. Another ex-
planation is that the gastric environment no longer suited
the growth conditions of H. pylori, and the bacteria could
not survive in conditions with extensive atrophy [45,46].
In order to evaluate validity of the Simple Model of
Stomach Age, we compared it with the results of FISH
intensity by paired-t test which indicated no difference
between them. The ability to predict disease’s prognosis
of Simple Model was evaluated by ROC curve with large
sample number, in which the cut-off point of Δage >3.11
is used to predict the high risk of getting poor prognosis
(sensitivity and specificity of 82.7% and 71.8%, respect-
ively). That means those patients with Δage >3.11 may
develop to a worse prognosis in the future which should
be closely follow-up and regularly examination of endos-
copy should be provided to them.
However, the majority of CAG patients observed for a
maximum of 16.5 years did not develop gastric cancer
[30], which suggested that a surveillance program for all
CAG patients may not be cost-effective. Our results
showed that a subset of patients at a higher risk for GC
could be easily identified by using the cut-off of Δage
>3.11 at the time of the CAG diagnosis, which poten-
tially enables these patients (Δage >3.11) to be selected
for warranted endoscopy surveillance without unneces-
sarily increasing the healthcare costs in this field.Conclusion
In conclusion, this study provides a definition of Stom-
ach Age, and demonstrates that people of the same true
age may have different Stomach Ages. Attention should
be paid to those with a greater Stomach Age than ex-
pected, especially in younger adults, as their mechanism
of CAG is pathologically different to those in elderly pa-
tients, with a greater risk of developing gastric cancer
over a lifetime. The Δage as calculated from the Simple
Model was related to the prognosis for developing wors-
ened CAG and the cut-off of >3.11 should be considered
as a criterion to select a subgroup of CAG patients for
gastric cancer surveillance.Competing interests
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